Literature DB >> 17199818

Heterozygote carrier testing in high schools abroad: what are the lessons for the U.S.?

Lainie Friedman Ross1.   

Abstract

The main value of carrier detection in the general population is to determine reproductive risks. In this manuscript I examine the practice of providing carrier screening programs in the school setting. While the data show that high school screening programs can achieve high uptake, I argue that this may reflect a lack of full understanding about risks, benefits, and alternatives, and the right not to know. It may also reflect the inherent coercion in group testing, particularly for adolescents who are prone to peer pressure. The problem of carrier screening in the schools is compounded when the condition has a predilection for certain groups based on race, ethnicity or religion. I examine programs around the world that seek to test high school students for Tay Sachs and Cystic Fibrosis carrier status. I argue that carrier programs should be designed so as to minimize stigma and to allow individuals to refuse. The mandatory school environment cannot achieve this. Rather, I conclude that screening programs should be designed to attract young adults and not adolescents to participate in a more voluntary venue.

Entities:  

Mesh:

Year:  2006        PMID: 17199818     DOI: 10.1111/j.1748-720X.2006.00096.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  8 in total

1.  A targeted population carrier screening program for severe and frequent genetic diseases in Israel.

Authors:  Joël Zlotogora; Rivka Carmi; Boaz Lev; Stavit A Shalev
Journal:  Eur J Hum Genet       Date:  2008-12-24       Impact factor: 4.246

2.  Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature.

Authors:  S Janssens; A De Paepe; P Borry
Journal:  J Community Genet       Date:  2012-12-29

Review 3.  Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.

Authors:  Jeffrey R Botkin; John W Belmont; Jonathan S Berg; Benjamin E Berkman; Yvonne Bombard; Ingrid A Holm; Howard P Levy; Kelly E Ormond; Howard M Saal; Nancy B Spinner; Benjamin S Wilfond; Joseph D McInerney
Journal:  Am J Hum Genet       Date:  2015-07-02       Impact factor: 11.025

4.  A Genomically Informed Education System? Challenges for Behavioral Genetics.

Authors:  Maya Sabatello
Journal:  J Law Med Ethics       Date:  2018-03-27       Impact factor: 1.718

5.  Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease.

Authors:  Alessandra Colaianni; Subhashini Chandrasekharan; Robert Cook-Deegan
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

6.  Carrier detection in childhood: a need for policy reform.

Authors:  Lainie Friedman Ross
Journal:  Genome Med       Date:  2010-04-22       Impact factor: 11.117

7.  High school Tay-Sachs disease carrier screening: 5 to 11-year follow-up.

Authors:  Helen Curd; Sharon Lewis; Ivan Macciocca; Margaret Sahhar; Vicki Petrou; Agnes Bankier; Sari Lieberman; Ephrat Levy-Lahad; Martin B Delatycki
Journal:  J Community Genet       Date:  2013-07-27

Review 8.  Tay-Sachs disease: current perspectives from Australia.

Authors:  Raelia M Lew; Leslie Burnett; Anné L Proos; Martin B Delatycki
Journal:  Appl Clin Genet       Date:  2015-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.